High permissivity of human HepG2 hepatoma cells for influenza viruses

Journal of Clinical Microbiology

Volumn 42, Issue 12, 2004, Pages 5861-5865

  Ollier, Laurence ^a   Caramella, Anne ^a   Giordanengo, Valérie ^a   Lefebvre, Jean Claude ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; TRYPSIN;

ARTICLE; CELL DESTRUCTION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; HEPATOMA CELL; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS REPLICATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOPATHOGENIC EFFECT, VIRAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LIVER NEOPLASMS; TISSUE PLASMINOGEN ACTIVATOR; VIRUS REPLICATION;

INFLUENZA A VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS B; RNA VIRUSES;

EID: 10844272132     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.12.5861-5865.2004     Document Type: Article

References (22)

1. Astedt, B. 1987. Clinical pharmacology of tranexamic acid. Scand. J. Gastroenterol. Suppl. 137:22-25.
2. Benders, A. A., T. H. van Kuppevelt, A. Oosterhof, and J. H. Veerkamp. 1991. The biochemical and structural maturation of human skeletal muscle cells in culture: the effect of the serum substitute Ultroser G. Exp. Cell Res. 195:284-294.
3. Dunn, C. J., and K. L. Goa. 1999. Tranexamic acid: a review of its use in surgery and other indications. Drugs 57:1005-1032.
4. Goto, H., and Y. Kawaoka. 1998. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc. Natl. Acad. Sci. USA 95:10224-10228.
5. Hajjar, K. A., and N. M. Hamel. 1990. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J. Biol. Chem. 265:2908-2916.
6. Hembrough, T. A., J. Vasudevan, M. M. Allietta, W. F. Glass II, and S. L. Gonias. 1995. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J. Cell Sci. 108:1071-1082.
7. Iwamoto, M. 1975. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin. Thromb. Diath. Haemorrh. 33:573-585.
8. Keskinen, P., M. Nyqvist, T. Sareneva, J. Pirhonen, K. Melen, and I. Julkunen. 1999. Impaired antiviral response in human hepatoma cells. Virology 263:364-375.
9. Kostka, V., and F. H. Carpenter. 1964. Inhibition of chymotrypsin activity in crystalline trypsin preparations. J. Biol. Chem. 239:1799-1803.
10. Krug, R. M. 1972. Cytoplasmic and nucleoplasmic viral RNPs in influenza virus-infected MDCK cells. Virology 50:103-113.
11. Lamb, R. A. 1989. Genes and proteins of the influenza viruses, p. 1-87. In R. M. Krug (ed.), The influenza viruses. Plenum Press, New York, N.Y.
12. Lazarowitz, S. G., A. R. Goldberg, and P. W. Choppin. 1973. Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology 56:172-180.
13. Lottenberg, R., U. Christensen, C. M. Jackson, and P. L. Coleman. 1981. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol. 80:341-361.
14. Malgaretti, N., L. Bruno, M. Pontoglio, G. Candiani, G. Meroni, S. Ottolenghi, and R. Taramelii. 1990. Definition of the transcription initiation site of human plasminogen gene in liver and non hepatic cell lines. Biochem. Biophys. Res. Commun. 173:1013-1018.
15. Nerlov, C., P. Rorth, F. Blasi, and M. Johnsen. 1991. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1592.
16. Nguyen, G., S. J. Self, C. Camani, and E. K. Kruithof. 1992. Characterization of the binding of plasminogen activators to plasma membranes from human liver. Biochem. J. 287:911-915.
17. Reina, J., V. Fernandez-Baca, I. Blanco, and M. Munar. 1997. Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture. J. Clin. Microbiol. 35:1900-1901.
18. Ronni, T., T. Sareneva, J. Pirhonen, and I. Julkunen. 1995. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 154:2764-2774.
19. Salgado, C. D., B. M. Farr, K. K. Hall, and F. G. Hayden. 2002. Influenza in the acute hospital setting. Lancet Infect. Dis. 2:145-155.
20. Simpson, J. L., I. Moric, P. A. Wark, S. L. Johnston, and P. G. Gibson. 2003. Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic techniques. J. Clin. Virol. 26:339-346.
21. Tree, J. A., C. Richardson, A. R. Fooks, J. C. Clegg, and D. Looby. 2001. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 19:3444-3450.
22. Yeoh, G., A. Douglas, and V. Brighton. 1986. Long-term culture of fetal rat hepatocytes in media supplemented with fetal calf-serum Ultroser SF or Ultroser G. Biol. Cell 58:53-63.